How to Save More on Rx Costs Without Risking Patient Satisfaction

Prescription Drug Spending in the U.S. increased to $307 billion dollars in 2010. By 2019, HHS predicts that U.S. drug spend will increase to $457.8 billion. Approximately 50 percent of the total bill is paid for by private health insurance plans. How do payers, who want their members to have necessary medications, rein in drug costs while ensuring quality care for patients? And when looking at reimbursement, are there pricing metrics and methods that can be utilized to reduce drug costs?

Have all available strategies been considered – such as employing a different, more effective drug price benchmark or looking beyond generics to reduce drug costs?

Download Whitepaper

About Clinical Solutions

Elsevier Clinical Solutions empowers healthcare providers and educates patients, driving the delivery of high quality, economically sound care through world-class clinical content integrated within clinical workflow and EHR systems.

Learn More